Literature DB >> 688734

Kinetics of norethindrone in women. II. Single-dose kinetics.

D J Back, A M Breckenridge, F E Crawford, M Mciver, M L Orme, P H Rowe, E Smith.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 688734     DOI： 10.1002/cpt1978244448

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  7 in total

Review 1.  Pharmacokinetics and potency of progestins used for hormone replacement therapy and contraception.

Authors:  Frank Z Stanczyk
Journal:  Rev Endocr Metab Disord       Date:  2002-09       Impact factor: 6.514

2.  The pharmacokinetics of ethinyloestradiol in women [proceedings].

Authors:  D J Back; H M Bolt; A M Breckenridge; F E Crawford; M MacIver; M L Orme; P H Rowe; A E Schindler; E Smith
Journal:  Br J Pharmacol       Date:  1979-07       Impact factor: 8.739

Review 3.  Clinical pharmacokinetics of oral contraceptive steroids.

Authors:  M L Orme; D J Back; A M Breckenridge
Journal:  Clin Pharmacokinet       Date:  1983 Mar-Apr       Impact factor: 6.447

Review 4.  Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effects.

Authors:  Frank Z Stanczyk; Janet P Hapgood; Sharon Winer; Daniel R Mishell
Journal:  Endocr Rev       Date:  2012-12-13       Impact factor: 19.871

Review 5.  Interindividual variation and drug interactions with hormonal steroid contraceptives.

Authors:  D J Back; A M Breckenridge; F E Crawford; M MacIver; M L Orme; P H Rowe
Journal:  Drugs       Date:  1981-01       Impact factor: 9.546

6.  Phenobarbitone interaction with oral contraceptive steroids in the rabbit and rat.

Authors:  D J Back; A M Breckenridge; F E Crawford; M L Orme; P H Rowe
Journal:  Br J Pharmacol       Date:  1980-07       Impact factor: 8.739

Review 7.  Pharmacokinetics, metabolism and serum concentrations of progestins used in contraception.

Authors:  Alexis J Bick; Renate Louw-du Toit; Salndave B Skosana; Donita Africander; Janet P Hapgood
Journal:  Pharmacol Ther       Date:  2020-12-13       Impact factor: 13.400
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.